ESC 2019: A review of SGLT2 inhibitors in HF - Prof Marc Sabatine & Prof Lars Kober

Prof Marc S Sabatine (Brigham and Women's Hospital, Boston, MA, US) and Prof Lars Kober (Copenhagen University Hospital, Copenhagen, DK) review the key clinical trials presented at the ESC 2019 on the topic of SGLT2 inhibitors in heart failure.

Filmed on site at ESC 2019 by Radcliffe Cardiology